This page is also available in: French
The Coalition is pleased to see INESSS inviting patient and patient group input when evaluating drugs for reimbursement in Quebec.
The patient perspective is an important one and what patients’ value in their treatment journey should be taken into consideration when deliberating on the reimbursement of a medication.
The Coalition would like to hear from Quebec-based patients/caregivers on INESSS’ efforts to incorporate the patient perspective into the drug approval process. Incorporating the patient perspective into the drug approval process aligns well with the Coalition Values to provide a strong voice for patients and those affected by cancer in Quebec.